“Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors-Reference-Cited by-同舟云学术

“Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors

Published:2016-12-31 Issue:14 Volume:8 Page:23891-23904
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Incorvaia Lorena¹,Passiglia Francesc¹,Rizzo Sergio¹,Galvano Antonio¹,Listì Angela¹,Barraco Nadia¹,Maragliano Rossella¹,Calò Valentina¹,Natoli Clara²,Ciaccio Marcello³,Bazan Viviana¹,Russo Antonio¹

Affiliation:

1. Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy

2. Department of Medical, Oral and Biotechnological Sciences, Centre of Ageing Sciences and Translational Medicine - CESI-MeT University “G. D'Annunzio”, Chieti, Italy

3. Section of Clinical Biochemistry and Clinical Molecular Medicine, Department of Biopathology and Medical Biotechnology, University of Palermo - U.O.C. Laboratory Medicine - CoreLab, Policlinico University Hospital, Palermo, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors;Cancer Gene Therapy;2024-08-09

2. Assessing the Phenotype of a Homologous Recombination Deficiency Using High Resolution Array-Based Comparative Genome Hybridization in Ovarian Cancer;International Journal of Molecular Sciences;2023-12-14

3. Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?;Cancer Treatment Reviews;2023-12

4. Contrasting roles of different mismatch repair proteins in basal-like breast cancer;2023-07-22

5. Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer;Frontiers in Pharmacology;2023-06-23